← Eichor
Condition: Hypercoagulability Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hypercoagulability

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07205861Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07513948A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induc
Phase 1 · 20 location(s) · Bayer · NCT06854640Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries
NA · 1 location(s) · Marianna Mavromati · NCT06717490A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
Phase N/A · 1 location(s) · Takeda · NCT06441578A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma
Phase N/A · 7 location(s) · Takeda · NCT07353099Observational Dutch Young Symptomatic StrokE studY - nEXT
Phase N/A · 6 location(s) · Radboud University Medical Center · NCT05853796Construction of a Database for TTP
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT05571774The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Phase 3 · 12 location(s) · University of Calgary · NCT06494878Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients S
Phase 3 · 27 location(s) · Octapharma · NCT06096116Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic AP
Phase N/A · 2 location(s) · Infanta Leonor University Hospital · NCT07372170A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency
Phase N/A · 1 location(s) · Takeda · NCT06590974Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study
Phase N/A · 1 location(s) · Turkish Hematology Association · NCT05950750Italian iTTP Registry
Phase N/A · 1 location(s) · Fondazione Luigi Villa · NCT06376786Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry
Phase N/A · 7 location(s) · Fundación Española de Hematología y Hemoterapía · NCT05914441Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Phase N/A · 7 location(s) · Insel Gruppe AG, University Hospital Bern · NCT01257269Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated Wi
Phase N/A · 1 location(s) · Guangdong Women and Children Hospital · NCT07571096ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
Phase N/A · 1 location(s) · University Hospital, Rouen · NCT06945861Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
Phase 2 · 1 location(s) · South West Sydney Local Health District · NCT05540834BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06794008Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
Phase N/A · 1 location(s) · BILLOIR · NCT05376046
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.